Krystal Biotech director Kirti Ganorkar resigns effective Dec 31, 2025

Krystal Biotech, Inc.

Kirti Ganorkar resigned from Krystal Biotech Board on Dec 22, 2025 due to time constraints from promotion to Managing Director at Sun Pharma.
Resignation not due to disagreement with Board or management; effective Dec 31, 2025.
Ganorkar served on Board since company's IPO in September 2017.
Board thanks him for contributions; no successor identified in filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.